BRIEF-FDA grants Roche label extension for cobas EGFR mutation test By: Reuters: Company News September 29, 2016 at 01:16 AM EDT * FDA grants Roche label extension for cobas egfr mutation test v2 for use with plasma as a companion diagnostic for Tagrisso Read More >> Related Stocks: Astrazeneca Plc ADR Rogers Corp